To qualify for Wegovy for CV risk reduction, you typically need: Established cardiovascular disease (prior heart attack, stroke, or peripheral artery disease), BMI 27 kg/m , and documentation of ongoing lifestyle modifications
Pancreatitis history History of pancreatitis: GLP-1 medications have been linked to a small but increased risk of pancreatitis, an inflammation of the pancreas
Like any medication, they carry potential side effects
If you have diabetes or are pre-diabetic, its best to talk to your healthcare provider before making changes to your treatment plan
Consistency with dosing, hydration, and protein intake becomes crucial at this stage
MINIMUM WAITING TIME Our patient-oriented processes ensure your waiting time is kept to a minimum